Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line

Mustafa Hammadi; Esam H. Hummadi; Rulla Sabah

doi:10.47750/pnr.2022.13.02.011

2022, Vol: 13, Issue: 2

13/2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Original Article

PNR. 2022; 13(2): 76-81

doi: 10.47750/pnr.2022.13.02.011

Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah.

Abstract
CuS nanoparticles were prepared in a novel way, and their efficacy as an anti-cancer agent was investigated, as well as their toxicity, using
a new, simple, easy, and low-cost method called chemical co-precipitation, which involved reacting dehydrated metal chloride salts of the
formula MCl2.2H2O with aqueous sodium sulfide of the formula Na2S.H2O under reaction conditions 0.5 M and the best pH 6 at 35°C. CuS
nanoparticles were identified using X-ray diffraction, FTIR spectroscopy, spectroscopy Energy-dispersive X-rays (EDX), scanning electron
microscopy (SEM), and the activity of the prepared CuS nanoparticles was investigated using an MTT test on the Mcf7 cell line. Graphpad
prism8.0 was used to perform statistical analysis on the results. CuS nanoparticles were 14.43 nm. The efficacy of CuS nanoparticles as an
anti-tumor agent was compared with letrozole the efficacy has been demonstrated using different concentrations on the Mcf7 cell line, with
the highest inhibition rate of 87.49 % after 24 hours and 95.67 % after 48 hours of incubation at a concentration of 400 g/ml, and the lowest
inhibition rate of 1.67 % after 24hrs and 6.35 % after 48 hrs at a concentration of 1.67 g/ml. The maximum percentage of inhibition is 84.61
% after 24 hours and 96.68 percent after 48 hours of incubation at 400 g/ml, while a minimum was 9.1 % after 24hrs and 18.24 after 48 hrs
at 25 g/ml

Key words: CuS nanoparticle, anticancer, MCF-7

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Mustafa Hammadi Articles by Esam H. Hummadi Articles by Rulla Sabah
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah. Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line. PNR. 2022; 13(2): 76-81. doi:10.47750/pnr.2022.13.02.011

Web Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah. Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line. https://www.pnrjournal.com/?mno=41045 [Access: August 11, 2022]. doi:10.47750/pnr.2022.13.02.011

AMA (American Medical Association) Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah. Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line. PNR. 2022; 13(2): 76-81. doi:10.47750/pnr.2022.13.02.011

Vancouver/ICMJE Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah. Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line. PNR. (2022), [cited August 11, 2022]; 13(2): 76-81. doi:10.47750/pnr.2022.13.02.011

Harvard Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah (2022) Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line. PNR, 13 (2), 76-81. doi:10.47750/pnr.2022.13.02.011

Turabian Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah. 2022. Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line. Journal of Pharmaceutical Negative Results, 13 (2), 76-81. doi:10.47750/pnr.2022.13.02.011

Chicago Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah. "Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line." Journal of Pharmaceutical Negative Results 13 (2022), 76-81. doi:10.47750/pnr.2022.13.02.011

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Mustafa Hammadi, Esam H. Hummadi, Rulla Sabah (2022) Synthesis of Cus Nanoparticle and Characterization, as well as Investigation of their Anticancer Activity Against A Human Breast Cancer Cell Line. Journal of Pharmaceutical Negative Results, 13 (2), 76-81. doi:10.47750/pnr.2022.13.02.011

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Journal of Pharmaceutical Negative Results are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Copyright � 2022 Journal of Pharmaceutical Negative Results All Rights Reserved. Subject to change without notice from or liability to Journal of Pharmaceutical Negative Results. For best results, please use Internet Explorer or Google Chrome	Contact Information ResearchTrentz Scientific Research Community Contact US 21, First Floor,ResearchTrentz (Registred Office) Thamotharan Street,India Email : editorial@pnrjournal.com, Support : pnrjournal@gmail.com

Contact Information

How to cite this article